Fundamentals of photodynamic therapy, clinical practice and prospects for use in pediatric surgery. Review

Cover Page

Cite item

Full Text

Abstract

The paper provides a review of domestic and foreign literature on photodynamic therapy, which is mainly used by oncologists in the treatment of adult patients and is little known to pediatric surgeons. The aim of this work is to describe the history of the formation, principles and mechanisms of photodynamic therapy, the main groups of photo sensitizers, areas of clinical application and prospects for wider use in pediatric surgery.

Literature sources were searched in the databases in Russian eLibrary and English Medline and PubMed. The following keywords were specified for the search: photodynamic therapy, dysplasia, metaplasia, angiodysplasia, Barrett’s syndrome, children. 865 papers were found, of which 66 were fully consistent with the purpose of our study and were analyzed.

The data presented in the review of the literature indicate the high efficiency of the method of photodynamic therapy in the treatment of a number of diseases, mostly in oncology. In addition, the work contains theoretical calculations and separate reports on the effectiveness of the method in the treatment of dysplasia of varying degrees in children.

Taking into account the minimally invasiveness of the technique, the relative cheapness of photosensitizers and equipment for generating laser radiation, it is possible to create a basis for conducting research on the treatment of children with various dysplasias, epithelial metaplasia, and vascular malformations. Another promising direction is the development of technologies for the use of photodynamic methods for the treatment of severe forms of pyoinflammatory diseases in children.

In childhood surgery, there are nosological forms of diseases where the method of photodynamic therapy has the prospect of effective use. Limitations on the scope of this article do not allow for a detailed analysis of the existing experience in the use of photodynamic therapy in children, which will need to be done in subsequent works.

About the authors

Saidkhasan M. Bataev

Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University

Email: khassan-2@yandex.ru
ORCID iD: 0000-0003-0191-1116
SPIN-code: 1247-1019

Dr. Sci. (Med.), Chief Researcher

Russian Federation, 29, Shmitovskiy proezd, Moscow, 123317

Konstantin S. Tsilenko

Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University

Email: 2408062@mail.ru
ORCID iD: 0000-0002-9088-1977
SPIN-code: 3246-1880

Research Associate

Russian Federation, Moscow

Anatoly N. Osipov

Pirogov Russian National Research Medical University

Email: anosipov@yahoo.com
ORCID iD: 0000-0001-7244-2818
SPIN-code: 3071-3803

Dr. Sci. (Biol.), Head of Department

Russian Federation, Moscow

Andrey V. Reshetnikov

Pirogov Russian National Research Medical University

Email: office@radapharma.ru
ORCID iD: 0000-0001-9413-4859
SPIN-code: 3273-4806

Cand. Sci. (Chem.)

Russian Federation, Moscow

Ali S. Bataev

Pirogov Russian National Research Medical University

Author for correspondence.
Email: bataev.ali@mail.ru
ORCID iD: 0000-0001-8166-1158
SPIN-code: 3472-2802

Clinical Resident

Russian Federation, Moscow

Sofya P. Sosnova

Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University

Email: s.s.petrovna@mail.ru
ORCID iD: 0000-0003-1227-3439
SPIN-code: 3532-1099

Pediatric Surgeon

Russian Federation, Moscow

References

  1. Kautsky H, Hirsch A. Neue Versuchezur Kohlensäure assimilation. Natur Wissenschaften. 1931;19:964. (In Deutsch) DOI: 10,1007/BF01516164
  2. Dougherty TJ, Henderson BW. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145–157. doi: 10.1111/j.1751-1097.1992.tb04222.x
  3. Slesarevskaya MN, Sokolov AV. Photodynamic therapy: basic principles and mechanisms of action. Urologicheskiye vedomosti. 2012;3:24–28. (In Russ.) doi: 10.17816/uroved2324-28
  4. Xue LY, Chiu SM, Azizuddin K, et al. Protection by Bcl-2 against apoptotic but not autophagic cell death after photodynamic therapy. Autophagy. 2008;4:125–127. doi: 10.4161/auto.5287
  5. Reiners JJ, Agostinis P, Berg K, et al. Assessing autophagy in the context of photodynamic therapy. Autophagy. 2010;6:7–18. doi: 10.4161/auto.5287
  6. Wei MF, Chen MW, Chen KC, et al Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Autophagy. 2014;10:1179–1192. doi: 10.4161/auto.28679
  7. Bonett R. Photosensitizers of the porphyrins and phtalocyanine series for photodynamic therapy. Chem Soc Rev. 1995;24:19–33. doi: 10.1039/CS9952400019
  8. Kato H, Konaka C, Kawate N, et al. Five-year disease-free survival of a lung cancer patient treated only by photodynamic therapy. Chest. 1986;90(5):768–770. doi: 10.1378/chest.90.5.768
  9. Furuse К, Fukuoka M, Kato H, et al. A prospective phase II study on photodynamic therapy with Photofrin II for centrally located early-stage lung cancer. J Clin Oncol. 1993;11:1852–1857.
  10. Stranadko EF. Lasernaya I magnitnaya terapiya v experementalnih I klinicheskih issledovaniyah. 1993;69–72. (In Russ.)
  11. Sobolev AS, Stranadko EPh. Photodynamic therapy in Russia: clinical and fundamental aspects. Int Photodynamics. 1997;6:2–3.
  12. Mongin O, Sankar M, Charlot M, et al. Strong enhancement of two-photon absorption properties in synergic ‘semi-disconnected’ multiporphyrin assemblies designed for combined imaging and photodynamic therapy. Tetrahedron Letters. 2013;54:6474–6478. doi: 10.1016/j.tetlet.2013.09.076
  13. Ying Z, Li X, Dang H. 5-aminolevulinic acid-based photodynamic therapy for the treatment of condylomata acuminata in Chinese patients: a meta-analysis. Photodermatol Photoimmunol Photomed. 2013;29(3):149–159. doi: 10.1111/phpp.12043
  14. Wachowska M, Muchowicz A, Firczuk M, et al. Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer. Molecules. 2011;16(5):4140–4164. doi: 10.3390/molecules16054140
  15. Sokolov VV, Chisov VI, Filonenko EB, at al. Fluorescence diagnostics and photodynamic therapy with photosens and alasens: experience of 11 years of clinical use. Russian Journal of Biotherapy. 2006;5:32–33. (In Russ.)
  16. Sessler JL, Miller RA. Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy. Biochem Pharmacol. 2000;59(7):733–739. doi: 10.1016/s0006- 2952(99)00314-7
  17. Moussaron A, Arnoux P, Vanderesse R, et al. Lipophilic phthalocyanines for their potential interest in photodynamic therapy: synthesis and photo-physical properties. Tetrahedron. 2013;69(47):10116–10122. doi: 10.1016/j.tet.2013.09.035
  18. Cakir D, Cakir V, Biyiklioglu Z, et al. New water soluble cationic zinc phthalocyanines as potential for photodynamic therapy of cancer. Journal of Organometallic Chemistry. 2013;745:423–431.
  19. Sokolova NV, Schotten T, Berthold HJ, et al. Microwave-assisted synthesis of triazole-linked phthalocyanine-peptide conjugates as potential photosensitizers for photodynamic therapy. Synthesis. 2013;45:556–561. doi: 10.1055/s-0032-1316845
  20. Smirnova ZS, Kubasova IYu, Makarova OA, et al. Preclinical study of the effectiveness of the liposomal dosage form of photosens for photodynamic therapy. Russian Journal of Biotherapy. 2003;2:40–46. (In Russ.)
  21. Asano R, Nagami A, Fukumoto Y, et al. Synthesis and biological evaluation of new chlorin derivatives as potential photosensitizers for photodynamic therapy. Bioorg Med Chem. 2013;21(8):2298–2304. doi: 10.1016/j.bmc.2013.02.005
  22. Zhang J, Deng L, Yao J, et al. Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy. Bioorg Med Chem. 2011;19(18):5520–5528. doi: 10.1016/j.bmc.2011.07.041
  23. Asano R., Nagami A., Fukumoto Y., et al. Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer. Bioorg Med Chem. 2014;24(5):1339–1343. doi: 10.1016/j.bmcl.2014.01.054
  24. Pandey RK, Sumlin AB, Constantine S, et al. Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic efficacy. Photochem Photobiol. 1996;64(1):194–204. doi: 10.1111/j.1751-1097.1996.tb02442.x
  25. Volgin VN, Stranadko EF, Sadovskaya MV, Ryabov MV. Experience in the application of photodynamic therapy of basal cell skin cancer of various localizations with a photosensitizer photoditazine. Russian Journal of Biotherapy. 2009;2:31–32. (In Russ.)
  26. Loshchenov VB, Linkov KG, Savelyeva TA. Hardware and tool equipment for fluorescence diagnostics and photodynamic therapy. Photodynamic Therapy and Photodyagnosis. 2013;2(3):17–25. (In Russ.)
  27. Yang E, Diers JR, Huang YY, et al. Molecular electronic tuning of photosensitizers to enhance photodynamic therapy: synthetic dicyanobacteriochlorins as a case study. Photochem Photobiol. 2013;89(3):605–618. doi: 10.1111/php.12021
  28. Huang P, Lin J, Wang S, et al. Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy. Biomaterials. 2013;34(19):4643–4654. doi: 10.1016/j.biomaterials.2013.02.063
  29. Wong TW, Aizawa K, Sheyhedin I, et al. Pilot study of topical delivery of monoL-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy. J Pharmacol Sci. 2003;93(2):136–142. doi: 10.1254/jphs.93.136
  30. Alberto ME, Marino T, Quartarolo AD, Russo N. Photophysical origin of the reduced photodynamic therapy activity of temocene compared to Foscan®: insights from theory. Phys Chem Chem Phys. 2013;15(38):16167–16171. doi: 10.1039/c3cp52698d
  31. Friaa O, Maillard P, Brault D. Reaction of the m-THPC triplet state with the antioxidant Trolox and the anesthetic Propofol: modulation of photosensitization mechanisms relevant to photodynamic therapy? Photochem Photobiol Sci. 2012;11(4):703–714. doi: 10.1039/c2pp05354c
  32. Goldman MP. Photodynamic therapy. Moscow: Reed Elsiver; 2010. P. 1–13. (In Russ.)
  33. Detty MR, Young DN, Williams AJ. A mechanism for heteroatom scrambling in the synthesis of unsymmetrical chalcogenopyrylium dyes. J Org Chem. 1995;60(20):6631–6634. doi: 10.1021/jo00125a066
  34. Hayata Y, Kato H, Konaka C, et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest. 1982;81(3):269–277. doi: 10.1378/chest.81.3.269
  35. Kato H, Sakai H, Kawaguchi M, et al. Experiences with Photodynamic Therapy in early gastric Cancer. Oncology Research and Treatment. 1992;15(3):232–237. doi: 10.1159/000217363
  36. Marcus S. Photodynamic Therapy of Human Cancer. Proc SPIE. 1992;80(6):869–889. doi: 10.1109/5.149450
  37. Kato H, Kawate N, Kinoshita K, et al. Photodynamic therapy of early-stage lung cancer. Ciba Found Symp. 1989;146:183–194; discussion 195–197. doi: 10.1002/9780470513842.ch13
  38. Ryabov MV, Stranadko EF. Photodynamic therapy of locally advanced skin cancer. Russian Journal of Biotherapy. 2004;3(2):56–57. (In Russ.)
  39. Betz CS, Rauschning W, Stranadko EP, et al. Long-term outcomes following Foscan®-PDT of basal cell carcinomas. Lasers Surg Med. 2012;44(7):533–540. doi: 10.1002/lsm.22056
  40. Rumyantseva VD, Mironov AF, Shamkhalov KS, et al. Ytterbium-porphyrine complexes as promising markers for tumour infra-red luminescence diagnostics. Laser Medicine. 2010;14(1):20–25. (In Russ.)
  41. Stranadko EF. Experimental and clinical development of a method for laser photodynamic therapy of malignant tumors using domestic photosensitizers of the first and second generation. Laser Market. 1994;11:20–26. (In Russ.)
  42. Volgin VN, Stranadko EF, Sokolova TV, et al. Optimization of photodynamic therapy for basal cell skin cancer with photosensitivity. Laser Medicine. 2007;11:50–54. (In Russ.)
  43. Chissov VI, Starinsky VV, Petrova GV, Editors. Zlokachestvennye novoobrazovaniya v Rossii v 2007 godu (zabolevaemost’ i smertnost’). Moscow: MNIOI im. P.A. Gertsena Rosmedtekhnologii; 2009. 242 p. (In Russ.)
  44. Yaitsky NA, Gerasin VA, Orlov SV. Photodynamic therapy in the treatment of lung cancer. Grekov’s Bulletin of Surgery. 2010; 169: 31–34. (In Russ.)
  45. Stranadko EPh, Mazurin VS, Shabarov VL. Photodynamic therapy in esophageal cancer. Photodiag Photodyn Ther. 2010;7(S1):S7–S8. doi: 10.1016/S1572-1000(10)70022-3
  46. Stranadko EF, Lobakov AI, Vasilenko YuV, et al. Fotodinamicheskaya terapiya raka bol’shogo duodenal’nogo sosochka i terminal’nogo otdela obshchego zhelchnogo protoka. Vestnik Moskovskogo Onkologicheskogo Obshchestva. 2007;4:5–6. (In Russ.)
  47. Titova VA. The role of photodynamic therapy in multimodality cancer treatment. Fotodinamicheskaya Terapiya i Fotodiagnostika. 2012;1:3–5. (In Russ.)
  48. Geynits AV, Mustafajev RD, Tikhov GV. Photodynamic therapy in treating peritonitis (experimental study). Photodiag Photodyn Ther. 2012;9(S1):S26–S27. doi: 10.1016/S1572-1000(12)70079-0
  49. Overholt BF, Panjehpour M. Barrett’s esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc. 1995;42(1):64–70. doi: 10.1016/s0016-5107(95)70246-6
  50. Prasad GA, Wang KK, Buttar NS, et al. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. Gastrointest Endosc. 2007;65(1):60–66. doi: 10.1016/j.gie.2006.04.028
  51. Peters F, Kara M, Rosmolen W, et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. Endoscopy. 2005;37(5):418–424. doi: 10.1055/s-2005-861198
  52. Overholt BF, Lightdale CJ, Wang KK, et al. International Photodynamic Group for High-Grade Dysplasia in Barrett’s Esophagus. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62(4):488–498. doi: 10.1016/j.gie.2005.06.047 Erratum in: Gastrointest Endosc. 2006;63(2):359.
  53. Overholt BF, Wang KK, Burdick JS, et al. International Photodynamic Group for High-Grade Dysplasia in Barrett’s Esophagus. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc. 2007;66(3):460–468. doi: 10.1016/j.gie.2006.12.037
  54. Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 1996;348(9027):584–585. doi: 10.1016/s0140- 6736(96)03054-1
  55. Mackenzie GD, Jamieson NF, Novelli MR, et al. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett’s esophagus. Lasers Med Sci. 2008;23(2):203–210. doi: 10.1007/s10103-007-0473-7
  56. Sokolov VV. Barretts esophagus (be) and early be cancer: effectiveness of various techniques in endoscopic treatment. Laser Medicine. 2011;15(2):44. (In Russ.)
  57. Sloeva AI, Ashurov ZM, Isaev VM, et al. Some aspects of the use of photodynamic therapy in patients with respiratory papillomatosis. Doctor-Ru. 2004:19. (In Russ.)
  58. Rostovtsev NM, Privalov VA, Kotlyarov AN, Makhalov AA. Primenenie radokhlorina pri fotodinamicheskoi terapii zabolevanii razlichnoi etiologii u detei. Pediatricheskii vestnik Yuzhnogo Urala. 2012;1:106–107. (In Russ.)
  59. Moreno-Arrones OM, Perez-Garcia B. Nevus sebaceus on the face: Experience with photodynamic therapy in adults and children. Indian J Dermatol Venereol Leprol. 2019;85(4):440. doi: 10.4103/ijdvl.IJDVL_1162_16
  60. Seitz G, Warmann SW, Armeanu S, et al. In vitro photodynamic therapy of childhood rhabdomyosarcoma. Int J Oncol. 2007;30(3):615–620.
  61. Seitz G, Krause R, Fuchs J, et al. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin. Oncol Rep. 2008;20(5):1277–1282.
  62. Chen M, Xie J, Han J. Photodynamic therapy of condyloma acuminatum in a child. Pediatr Dermatol. 2010;27(5):542–544. doi: 10.1111/j.1525-1470.2010.01279.x
  63. Kumar N, Warren CB. Photodynamic therapy for dermatologic conditions in the pediatric population: a literature review. Photodermatol Photoimmunol Photomed. 2017;33(3):125–134. doi: 10.1111/phpp.12296
  64. Fekrazad R, Seraj B, Chiniforush N, et al. Effect of antimicrobial photodynamic therapy on the counts of salivary Streptococcus mutans in children with severe early childhood caries. Photodiagnosis Photodyn Ther. 2017;18:319–322. doi: 10.1016/j.pdpdt.2017.03.007
  65. Bargrizan M, Fekrazad R, Goudarzi N, Goudarzi N. Effects of antibacterial photodynamic therapy on salivary mutans streptococci in 5- to 6-year-olds with severe early childhood caries. Lasers Med Sci. 2019;34(3):433–440. doi: 10.1007/s10103-018-2650-2
  66. Ribeiro da Silva VC, da Motta Silveira FM, Barbosa Monteiro MG, et al. Photodynamic therapy for treatment of oral mucositis: Pilot study with pediatric patients undergoing chemotherapy. Photodiagnosis Photodyn Ther. 2018;21:115–120. doi: 10.1016/j.pdpdt.2017.11.010

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies